Reference is made to the Extraordinary General Meeting in IDEX Biometrics ASA ("IDEX" or the "Company") on 11 April 2025, where all proposed resolutions were approved.
Key information relating to the approved share consolidation:
Date on which the terms and conditions of the share consolidation was made public: 11 April 2025;
Share consolidation ratio: 100 old shares give 1 new share;
Last day including right: 10 June 2025;
Ex-date: 11 June 2025;
Record date: 12 June 2025; and
Date of approval: 11 April 2025
In connection with the share consolidation, the Company's shares will be transferred to a new ISIN. Please find below the following key information for the change of ISIN:
Issuer: IDEX Biometrics ASA
Old ISIN: NO0013107490
New ISIN: NO0013536078
Date of ISIN change: 11 June 2025.
For further information contact:
Marianne Bøe, Head of Investor Relations, Tel: +47 91800186
Kristian Flaten, CFO, Tel: +47 95092322
E-mail: ir@idexbiometrics.com
About IDEX Biometrics:
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.
For more information, visit www.idexbiometrics.com
About this notice:
This notice was published by Kristian Flaten, CFO in IDEX Biometrics ASA, on 11 April 2025 at 16:50 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12 and Euronext Oslo Børs rule book.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。